About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Vhl+
wild type
MGI:2154489
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
ht1
Vhltm1.1Jae/Vhl+ involves: 129S4/SvJae * BALB/c MGI:2174802
ht2
Vhltm1Wml/Vhl+ involves: 129S4/SvJae * C57BL/6 MGI:5766045
ht3
Vhltm1.1Wkr/Vhl+ involves: 129S4/SvJae * C57BL/6 MGI:4436912
ht4
Vhltm1.1Lss/Vhl+ involves: A/J MGI:2677768
ht5
Vhltm1.1Lss/Vhl+ involves: BALB/c MGI:2677767


Genotype
MGI:2174802
ht1
Allelic
Composition
Vhltm1.1Jae/Vhl+
Genetic
Background
involves: 129S4/SvJae * BALB/c
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Vhltm1.1Jae mutation (0 available); any Vhl mutation (17 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Vascular tumors in Vhltm1.1Jae/Vhl+ livers and vascular lesions in Vhltm1Jae/Vhltm1Jae Speer6-ps1Tg(Alb-cre)21Mgn/0 mice

neoplasm
• carvernous hemangiomas are found in 50% of heterozygotes between 3 and 12 months of age and in 90% between 12 and 17 months of age
• in extreme cases the hemangioma affects the entire liver
• associated with steatosis and focal proliferation of small vessels and spindle cells

liver/biliary system
• associated with hemangiomas
• carvernous hemangiomas are found in 50% of heterozygotes between 3 and 12 months of age and in 90% between 12 and 17 months of age
• in extreme cases the hemangioma affects the entire liver
• associated with steatosis and focal proliferation of small vessels and spindle cells

cardiovascular system
• focal proliferation of small vessels in the liver

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
von Hippel-Lindau disease DOID:14175 OMIM:193300
J:67505




Genotype
MGI:5766045
ht2
Allelic
Composition
Vhltm1Wml/Vhl+
Genetic
Background
involves: 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Vhltm1Wml mutation (0 available); any Vhl mutation (17 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• increased incidence of vascular neoplasms in the liver, uterus, ovary, spleen and heart in response to streptozotocin, compared to controls
• highest incidence and number found in liver
• lesions seen: angiectasia, hemangisarcoma, hemangioma
• no increase in renal lesions in response to streptozotocin, compared to controls

neoplasm
• increased incidence of vascular neoplasms in the liver, uterus, ovary, spleen and heart in response to streptozotocin, compared to controls
• highest incidence and number found in liver
• lesions seen: angiectasia, hemangisarcoma, hemangioma
• no increase in renal lesions in response to streptozotocin, compared to controls




Genotype
MGI:4436912
ht3
Allelic
Composition
Vhltm1.1Wkr/Vhl+
Genetic
Background
involves: 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Vhltm1.1Wkr mutation (1 available); any Vhl mutation (17 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• enlarged blood vessels in kidneys and adrenal glands at 12 months of age

renal/urinary system
• renal cortical microcysts found at 12 months

liver/biliary system
N
• normal liver histology at 12 months

neoplasm
• in kidney papillary cysts as a result of transplacental ENU mutagenesis

homeostasis/metabolism

growth/size/body
• renal cortical microcysts found at 12 months

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
von Hippel-Lindau disease DOID:14175 OMIM:193300
J:157369




Genotype
MGI:2677768
ht4
Allelic
Composition
Vhltm1.1Lss/Vhl+
Genetic
Background
involves: A/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Vhltm1.1Lss mutation (0 available); any Vhl mutation (17 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
liver/biliary system
• 66% showed hepatic vascular lesions on a A/J genetic background

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
von Hippel-Lindau disease DOID:14175 OMIM:193300
J:85513




Genotype
MGI:2677767
ht5
Allelic
Composition
Vhltm1.1Lss/Vhl+
Genetic
Background
involves: BALB/c
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Vhltm1.1Lss mutation (0 available); any Vhl mutation (17 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• 88% showed hepatic hemangiomas by 18 months of age, on a BALB/c genetic background

liver/biliary system
• 88% showed hepatic hemangiomas by 18 months of age, on a BALB/c genetic background

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
von Hippel-Lindau disease DOID:14175 OMIM:193300
J:85513





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/18/2025
MGI 6.24
The Jackson Laboratory